Groundbreaking Skin Treatment Shows 100% Response Rate ENV-294 Delivers Exceptional Results for Severe Eczema Patients In remarkable Phase 1b trial results that have surprised even researchers, Enveda's experimental treatment ENV-294 achieved a 100% response rate in patients with moderate to severe atopic dermatitis — a condition that affects millions